|
參考文獻 1. Castelli, W.P. (1986). The triglyceride issue: a view from Framingham. Am. Heart. J. 112:432. 2. Brunzell, J.D. (1995). Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: The Metabolic and Molecular Basis of Inherited Disease (Scriver, C.R., Beaudet, A.L., Sly, W.S., and Valle, D., eds.), pp. 1913-1932. McGraw-Hill, New Yor. 3. Havel, R.J. and Gordon, Jr. R.S. (1960). Idiopathic hyperlipemia: Metabolic studies in an affected family. J. Clin. Invest. 39:1777. 4. Huttunen, J.K., Ehnholm, C., Kekki, M., and Nikkila, E.A.(1976). Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism. Clin. Sci. and Mol. Med. 50:249. 5. Breckenridge, W.C., Little, J.A., Steiner, G., Doow, A., and Poapst, M. (1978). Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N. Engl. J. Med. 298 (23):1265. 6. Brunzell, J.D., Miller, N.E., Alauporia, P. et al. (1983). Familial chylomicronemia due to circulating inhibitor of lipoprotein lipase activity. J. Lipid Res. 24(1):12. 7. Kihara, S., Matsuzawa, Y., Kubo, M., Nozaki,S., Funahashi, T., Yamashita, S., Sho, N., and Tarui, S. (1989). Autoimmune hyperchylomicronemia. N. Engl. J. Med. 320 (19):1255. 8. Langlois, S., Deeb, S.S., Brunzell, J.D., Kastelein, J.J. and Hayden, M.R. (1989). A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency. Proc. Natl. Acad. Sci. USA. 86(3):948. 9. Fisher, R.M., Mailly, F., Peacock, R.E., Hamsten, A., Seed, M., Yudkin, J.S., Beisiegel, U., Feussner, G., Miller, G., Humphries, S.E., and Talmud, P.J. (1995). Interaction of the lipoprotein lipase asparagine-291-serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J. Lipid Res. 36:2104. 10. Reymer, P.W.A., Gagne, E., Groenemeyer, B.E., Zhang, H., Forsyth, I., Jansen, H., Seidell, J.C, Kromhout, D., Lie, K.E., Kastelein, J., and Hayden, M.R. (1995). A lipoprotein lipase mutation(Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nature Genet. 10:28. 11. Wittekoek, M.E., Pimstone, S.N., Reymer, P.W.A., Lisette, F., Botma G.J., Defesche, J.C., Hayden, M.R., and Kastelein, J.J.P. (1998). A common mutation in the lipoprotein lipase gene (N291S) alters the lipoprotein phenotype and risk for cardiovascular disease in patients with familial hypercholesterolemia. Circulation. 97:729. 12. Yang, W-S., Nevin, D.N., Peng, R., Brunzell, J.D., and Deeb, S.S. (1995). A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc. Natl. Acad. Sci. USA 92:4462. 13. Wilson, D.E., Hata, A., Kwong, L.K., Lingam, A., Shuhua, J., Ridinger, D., Yeager, C., Kaltenborn, K.C., Iverius, P.H., and Lalouel, J.M. (1993). Mutations in exon 3 of the lipoprotein lipase gene segregation in a family with hypertriglyceridemia, pancreatitis and non-insulin- dependent diabetes. J. Clin. Invest. 92:203. 14. Hopfer, U. (1986). In Biochemistry(Devlin, T., ed.), pp.931- 938. John Wiley and Sons. New York 15. Jackson, R.L. (1983). Lipoprotein lipase and hepatic lipase. In “The enzymes”(Boyer, P.D. eds.), Academic press.Vol. XVI:141-181. 16. Brunzell, J.D. (1989). In the Metabolic Basis of Inherited Disease(Scriver, C.R., Beaudet, A.L. and Valle, D., eds.), pp. 1165-1180. McGraw-Hill, New York 17. Hahn, P.F. (1943). Abolishment of alimentary lipemia following injection of heparin. Science. 98:166. 18. Korn, E.D. (1954). Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J. Biol. Chem. 215:1. 19. Korn, E.D. (1954). Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil. J. Biol. Chem. 215:15. 20. LaRosa, J.C., Levy, R.I., Windmueller, H.G., and Fredrickson, D.S. (1972). Comparison of the triglyceride lipase of liver, adipose tissue, and postheparin plasma. J. Lipid Res. 13(3):356. 21. Krauss, R.M., Hebert, P.N., Levy, R.I., and Fredrickson, D.S. (1973). Further observation on the activation and inhibition of lipoprotein lipase by apolipoprotein. Circulation Res. 33(4):403. 22. Krauss, R.M., Windmueller, H.G., Levy, R.I. and Fredrickson, D.S. (1973). Selective measurement of two different triglyceride lipase activities in rat postheparin plasma. J. Lipid Res. 14:286. 23. Murthy, V., Julien, P., and Gagne, C. (1996). Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol. Ther. 70(2):101. 24. Braun, J.E., and Severson, D.L. (1992). Regulation of the synthesis, processing and translocation of lipoprotein lipase. Biochemical J. 287:337. 25. Bengtsson, G. and Olivecrona, T. (1977). Interaction of lipoprotein lipase with heparin-Sepharose. Evaluation of conditions for affinity binding. Biochemical J. 167:109. 26. Wong, H., Davis, R.C., Thuren, T., Goers, J.W., Nikazy, J., Waite, M., and Schotz, M.C. (1994). Lipoprotein lipase domain function. J. Biol. Chem. 269(14):10319. 27. Nilsson-Ehle, P., Garfinkel, A.S., and Schotz, M.C. (1980). Lipolytic enzymes and plasma lipoprotein metabolism. Annu. Rev. Biochem. 49:667. 28. Fojo, S.S., and Brewer, H.B. (1992). Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. J. Int. Med. 231(6):669. 29. Benlian, P., De Gennes, J.L., Foubert, L., Zhang, H., Gagne, S.E., and Hayden, M. (1996). Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N. Engl. J. Med. 335:848. 30. Sparkes, R.S., Zollman, S., Klisak, I., et al. (1987). Human genes involved in lipolysis of plasma lipoprotein: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21. Genomics 1:138. 31. Wion, K.L., Kirchgessner, T.G., Lusis, A.J., Schotz, M.C., and Lawn, R.M. (1987). Human lipoprotein lipase complementary DNA sequence. Science 235:1638. 32. Deeb, S.S., Peng, R. (1989). Structure of the human lipoprotein lipase gene. [published erratum appears in Biochemistry 1989 Aug 8; 28(16):6786]. Biochemistry 28(10):4131. 33. Kirchgessner, T.G., Svenson, K.L., Lusis, A.J., and Schotz, M.C. (1987). The sequence of cDNA encoding lipoprotein lipase. A member of a lipase gene family. J. Biol. Chem. 262(18):8463. 34. Ma, Y., Henderson, H., Murthy, V.M.R. et al. (1991). A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians. N Engl. J. Med. 324:1761. 35. Bergeron, J., Normand, T., Bharucha, A., Murthy, V.M.R., Julien, P., Gagne, C. et al. (1992). Prevalence, geographical distribution and genealogical investigations of mutation 188 of lipoprotein lipase gene in the French Canadian population of Quebec. Clin. Genet. 41:206. 36. Minnich, A., Kessling, A., Roy M., Giry, C., et al. (1995). Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent. J. Lipid Res. 36:117. 37. Rouis, M., Lohse, P., Dugi, K.A., et al. (1996). Homozygosity for two point mutations in the lipoprotein lipase (LPL) gene in a patient with familial LPL deficiency:LPL(Asp9→Asn, Tyr262→His). J. lipid. Res. 37:651. 38. Bruin, T., Tuzgol, S., Mulder, W.J., van den Ende, A.E., Jansen, H., Hayden, M.R. and Kastelein, J.J.P. (1994). A compound heterozygote for lipoprotein lipase deficiency, Val69→Leu and Gly188→Glu: correlation between in vitro LPL activity and clinical expression. J. Lipid Res. 35(3):438 39. Takagi, A., Ikeda, Y., Mori, A., Tssutsumi, Z., Oida, K., Nakai, T., and Yamamoto A. (1994). A newly identified heterozygous lipoprotein lipase gene mutation (Cys239→stop/TGC972→TGA; LPLobama) in a patient with primary type IV hyperlipoproteinemia. J. Lipid Res. 35(11):2008. 40. Mailly, F., Tugrul, Y., Reymer, P.W.A., Bruin, T., Seed, M., et al. (1995). A common variant in the gene for lipoprotein lipase (Asp9→Asn). Functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler. Thromb. Vasc. Biol. 15(4):468. 41. Reymer, P.W.A., Groenemeyer, B.E., Gagne, E., Miao, L., Appelman, E.E., Seidel, J.C., Kromhout, D., Bijvoet, S.M., van de Oever, K. and Bruin, T. et al. (1995). A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Human Mol. Genet. 4(9):1543. 42. Nevin, D.N., Brunzell, J.D., and Deeb, S.S. (1994). The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity. Arterioscler. Thromb. 14:869. 43. Gagne, E., Genest, Jr.J., Zhang, H., Clarke, L.A., and Hayden, M.R. (1994). Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia. Aterioscler. Thromb. 14(8):1250. 44. Wison, D.E., Emi, M., Iverius, P-H., Hata, A., Wu, L.L., Hillas, E., Williams, R.R., and Lalouel, J-M. (1990). Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J. Clin. Invest. 86:735. 45. Gotoda, T., Yamada, N., Kawamura, M., Kozaki, K., et al. (1991). Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency. J. Clin. Invest. 88:1856. 46. Ma, Y., Liu, M-S., Ginzinger, D., Frohlich, J., Brunzell, J.J., and Hayden, M.R. (1993). Gene-Environment interaction in the conversion of a mild-to-severe phenotype in a patient homozygous for a Ser172→Cys mutation in the lipoprotein lipase gene. J. Clin. Invest. 91:1953. 47. Hayden, M.R., Liu, M-S., and Ma, Y. (1994). Gene environment interaction and plasma triglyceride levels: the crucial role of lipoprotein lipase. Clin. Genet. 46:15. 48. Shigeki, S., Tamasawa N., Kinpara I., Murakami, H., Kasai, N., Onuma T., Ikeda Y., Takagi A., and Suda, T. (1998). Identification of homozygous lipoprotein lipase gene mutation in a woman with recurrent aggravation of hypertriglyceridaemia induced by pregnancy. J. Intern. Med. 243:317. 49. Weintraub, M.S., Eisenberg, S., and Breslow, J.L. (1987). Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J. Clin. Invest. 80:1571. 50. Reymer, P.W.A., Gagne, E., Groenemeyer, B.E., Zhang, H., et al. (1995). A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Natu. Genet. 10:28. 51. Syvanne, M., Antikainen, M., Ehnholm, S., Tenkanen, H., et al. (1996). Heterozygosity for Asn291→Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia. J. Lipid Res. 37:727. 52. Fisher, R.M., Humphries, S.E., and Talmud, P.J. (1997). Common variation in the lipoprotein lipase gene: effect on plasma lipids and risk of atherosclerosis. Atherosclerosis 135:145. 53. Saambrook, J., Fritsch, E.F. and Maniatis, T. (1982). Molecular cloning(1st and 2nd editions). Cold Spring Harbor, New York 54. Saiki, R.K., Gelfand, D.H., Stoffel, S.J., Higuchi, R., Horn, G.T., Mullis, K.B., and Erlich, H.A. (1988). Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 239(4839):487. 55. Monsalve, M.V., Henderson, H., Roederer, G., Julien, P., Deeb, S.S., Kastelein, J.J.P., et al. (1990). A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries. J. Clin. Invest. 86:728. 56. Orita, M., Iwahana, H., Kanazawa, H., Hayashi,K., and Sekiya, T. (1989). Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphism. Proc. Natl. Acad. Sci. USA. 86(8):2766. 57. Orita, M., Suzuku, Y., Sekiya, T., and Hayashi, K. (1989). Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 5(4):874. 58. Iwahana, H., Yoshimoto, K., and Itakara, M. (1992). Detection of point mutations by SSCP or PCR-amplified DNA after endonuclease digestion. Biotechniques. 12(1):64. 59. Spinardi, L., Mazars, R., and Theillet, C. (1991). Protocols for an improved detection of point mutations by SSCP. Nuc. Acid Res. 19(14):4009. 60. Sanger, F., Niklen, S., and Coulson, A.R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Nat. Acad. Sci. USA. 74:5463. 61. Krauss, R.M., Levy, R.I., and Fredrickson D.S. (1974). Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. J. Clin. Invest. 54:1107. 62. Ehnholm, C., and T. Kuusi. (1986). Preparation, characterization and measurement of hepatic lipase. Meth. In Enzymo. 129:716. 63. Takeyoshi, M., Miyashita Y., Itoh, Y., Tsuzuki, S., Yamamori, S., Watanabe, H., and Shirai, K. (1998). Incidence of lipoprotein lipase genotype for premature termination codon (Ser447 - Ter) in Japanese, and association with dyslipoproteinemia. Clinica Chimica Acta 275:205. 64. Zhang, H., Henderson, H., Gagne, S.E., Clee, S.M., Miao, L., Liu, G., and Hayden, M.R. (1996). Common sequence variants of lipoprotein lipase: Standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta 1302:159. 65. Humphries, S.E., Nicaud, V., Margalef, J., Tiret, L., and Talmud, P.J. (1998). Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides. Arterioscler. Thromb. Vasc. Biol. 18:526. 66. Hide, W.A., Chan, L., and Li, W.H.(1992) Structure and evolution of the lipase superfamily. J. Lipid Res. 33(2):167.
|